# Restricted Intravenous Fluid Regime Effects on Immunological Indicators of Elderly Patients Operated for Abdominal Cancer

> **NCT01399814** · PHASE3 · COMPLETED · sponsor: **Nanjing PLA General Hospital** · enrollment: 179 (actual)

## Conditions studied

- Surgery
- Perioperative Care
- Immunization
- Abdominal Neoplasms

## Interventions

- **BEHAVIORAL:** perioperative fluid management
- **BEHAVIORAL:** perioperative fluid treatment

## Key facts

- **NCT ID:** NCT01399814
- **Lead sponsor:** Nanjing PLA General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-05
- **Primary completion:** 2010-10
- **Final completion:** 2010-10
- **Target enrollment:** 179 (ACTUAL)
- **Last updated:** 2011-07-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01399814

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01399814, "Restricted Intravenous Fluid Regime Effects on Immunological Indicators of Elderly Patients Operated for Abdominal Cancer". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT01399814. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*